Mercado global de cirurgia de cardiologia robotizada – Tendências do setor e previsão para 2031

Análise e tamanho do mercado de cirurgia de cardiologia robótica

O mercado da cirurgia cardiológica robótica continua a crescer com os avanços na tecnologia e nos métodos. Os mais recentes sistemas robóticos melhoram a precisão e a eficiência em procedimentos cardíacos complexos, impulsionando o crescimento do mercado. Os cirurgiões utilizam cada vez mais estas inovações para melhorar os resultados dos doentes, reduzir os tempos de recuperação e enfrentar condições cardiovasculares desafiantes com maior precisão. Esta tendência sublinha uma mudança transformadora em direção às intervenções assistidas por robótica em cardiologia.                               

O tamanho do mercado global de cirurgia cardiológica robótica foi avaliado em 587,54 milhões de dólares em 2023, deverá atingir 1.584,20 milhões de dólares até 2031, com um CAGR de 13,20% durante o período de previsão de 2024 a 2031. Isto indica que o valor de mercado. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito do relatório e segmentação de mercado

Definição de mercado

Robotic cardiology surgery refers to advanced procedures where robotic systems assist cardiologists in performing intricate cardiac surgeries with high precision. These systems use miniaturized instruments controlled by surgeons via computer console, enhancing accuracy and reducing recovery times compared to traditional methods. Robotic technology allows for minimally invasive procedures, reducing risks and improving outcomes for patients undergoing complex heart surgeries.            

Robotic Cardiology Surgery Market Dynamics

Drivers

• Increasing Telemedicine and Remote Surgery

Advances in robotic technology have revolutionized cardiology surgery by enabling telemedicine applications. Expert surgeons can now remotely perform complex procedures using robotic systems, expanding access to specialized care in remote or underserved areas. For instance, a surgeon in a major city can guide and operate a robotic system in a rural hospital, providing high-quality cardiac surgery without patients needing to travel long distances. This capability significantly drives market growth by enhancing accessibility and improving patient outcomes.

• Growing Minimally Invasive Surgery

Minimally invasive robotic surgery in cardiology allows surgeons to perform intricate procedures through small incisions, such as mitral valve repairs or coronary artery bypass grafting. This approach minimizes trauma to the patient's body, leading to faster recovery times and reduced risks of infection and bleeding compared to traditional open-heart surgery. As patients experience quicker healing and fewer complications, the demand for robotic cardiac surgery systems grows, driving market expansion globally.

Opportunities

• Growing Aging Population

As the global population ages, there is a rising need for cardiovascular treatments. Robotic surgery meets this demand by offering precise and effective procedures, appealing to both patients and healthcare providers. For instance, in developed countries such as the United States and Japan, where aging demographics are prominent, the adoption of robotic cardiology surgery has surged. This trend underscores the market's growth as it addresses the specific healthcare needs of an aging population effectively.

• Improved Patient Recovery

The adoption of minimally invasive robotic procedures in cardiology surgery is driving market growth by significantly improving patient recovery times. Compared to traditional open-heart surgeries, these advanced techniques often lead to shorter hospital stays and quicker rehabilitation periods. For instance, studies have shown that patients undergoing robotic-assisted heart surgery generally experience reduced pain and faster return to normal activities, which not only enhances patient outcomes but also increases demand for robotic systems in cardiac care.

Restraints/Challenges

• Risk of Technical Failures

The risk of technical failures in robotic systems during surgeries poses a significant barrier to market growth, as potential malfunctions may compromise patient safety and undermine confidence in the technology's reliability. This concern discourages widespread adoption among healthcare providers and patients. 

• High Cost of Robotic Systems

The high cost of robotic surgery systems limits their adoption in smaller healthcare facilities and developing regions, hindering market expansion. This financial barrier restricts access to advanced surgical technology, potentially disadvantaging patients who could benefit from robotic procedures. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2022, MedTech start-up SS Innovations expanded its global presence by acquiring Avra Medical Robotics, a U.S. company specializing in surgical robot devices. This acquisition positions SS Innovations to enhance its capabilities and reach in the healthcare sector, aiming to innovate and improve surgical outcomes worldwide
• In November 2022, Accelus achieved U.S. FDA approval for its Remi Robotic Navigation System software update, enabling robotic-assisted pedicle screw placement in lumbar spine fixation surgeries. This milestone enhances Accelus's mission to advance minimally invasive surgery standards, offering surgeons precise tools for improved patient outcomes in spinal procedures
• In November 2022, Smith+Nephew introduced the JOURNEY II ROX Total Knee Solution, a reverse hybrid construct for total knee arthroplasty. Combining advanced bearing materials and anatomic design with cementless tibia fixation, this innovation aims to optimize surgical efficiency and potentially improve long-term outcomes for patients undergoing knee replacement
• In February 2022, Smith+Nephew launched its CORI Surgical System, a next-generation handheld robotics platform, in Japan. This advancement underscores Smith+Nephew's commitment to technological innovation in surgical robotics, empowering Japanese healthcare providers with advanced tools for precise and efficient orthopedic procedures

Robotic Cardiology Surgery Market Scope

The market is segmented on the basis of product and service, equipment type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• Robotic Systems
• Instruments and Accessories
• Maintenance Services
• System Services

 Equipment Type

• Robot Machines
• Navigation Systems
• Planners and Simulators
• Others

End User

• Hospitals
• Research Centers

Robotic Cardiology Surgery Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product and service, equipment type, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the robotic cardiology surgery market in terms of both market share and revenue, bolstered by flexible regulatory frameworks and increasing adoption of innovative, technologically advanced products. This trend is anticipated to persist throughout the forecast period.

Europe is projected to exhibit the highest growth rate in the robotic cardiology surgery market, driven by expanding healthcare infrastructure and flexible compliance standards. These factors facilitate advancements in robotic surgery, enhancing precision and outcomes in cardiac procedures across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do cenário competitivo e da quota de mercado da cirurgia de cardiologia robótica

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Siemens Medical Solutions USA, Inc.
•  Medical Device Business Services, Inc. (EUA)
• Intuitive Surgical Operations, Inc. (EUA)
• Precisão Incorporada. (NÓS)
•  Johnson & Johnson Private Limited (EUA)
• CAE Inc. (Canadá)
• Medtronic (Irlanda)
• meerecompany Inc. (Coreia do Sul)
• Ciência Cirúrgica Suécia AB (EUA)
• (Canadá)
• Asensus Surgical US, Inc.
• Siemens Healthineers AG (Alemanha)

SKU-50558